Shangya Technology Co., Ltd. (TPEX:6130)
Taiwan · Delayed Price · Currency is TWD 39.50
+2.45 (6.61%)
Feb 11, 2026, 1:33 PM CST
Shangya Technology Market Cap
Shangya Technology has a market cap or net worth of 1.75 billion as of February 13, 2026. Its market cap has increased by 72.11% in one year.
Market Cap
1.75B
Enterprise Value
1.82B
Revenue
159.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
39.50
Market Cap Chart
Since November 3, 2004, Shangya Technology's market cap has increased from 885.72M to 1.75B, an increase of 97.56%. That is a compound annual growth rate of 3.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.75B | -11.24% |
| Dec 31, 2025 | 1.97B | 88.96% |
| Dec 31, 2024 | 1.04B | -31.54% |
| Dec 29, 2023 | 1.52B | 15.05% |
| Dec 30, 2022 | 1.32B | -7.53% |
| Dec 30, 2021 | 1.43B | 117.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 268.14B |
| Caliway Biopharmaceuticals | 248.00B |
| Lotus Pharmaceutical | 76.92B |
| Heron Neutron Medical | 74.10B |
| GeneFerm Biotechnology | 1.81B |
| Genomics BioSci & Tech. | 1.79B |
| Chi Sheng Pharma & Biotech | 1.78B |
| Tien Liang BioTech | 1.76B |